The linearity curves were found to be linear over 10-150 µg/ml for high performance thin layer chromatography and 100-600 ng/spot for high performance thin layer chromatography. The limit of detection and limit of quantifi cation for high performance thin layer chromatography were found to be 2.0 and 10 µg/ml, respectively, and for the high performance thin layer chromatography, 30 and 100 ng/spot, respectively. The proposed methods were successfully used for estimation of nebivolol hydrochloride in tablet dosage form.
Nebivolol is chemically, α,α 1 -[imino bis (methylene)]bis[6-fluoro-3,4-dihydro-2H -1-benzopyran-2-methanol] 1 , which is a selective β 1 -receptor antagonist without partial agonist activity 2 . Liquid chromatography-mass spectroscopic (LC-MS) methods [3] [4] [5] for analysis of nebivolol in biological fluids, are reported in the literature. The present investigation describes two precise, accurate and specific, reverse phase high performance liquid chromatography (RP-HPLC) and high performance thin layer chromatography (HPTLC) methods for the estimation of nebivolol hydrochloride in tablet formulation.
All the reagent used were of HPLC and analytical Linearity of the method was investigated by serially diluting the stock solution to give a concentration range of 10 to 150 μg/ml and injected 20 μl with universal injector 77251(Rheodyne). The ß ow rate was maintained at 1.0 ml/min. Temperature of the column was kept ambient and the efß uent was monitored at 282 nm. Calibration curve was constructed by plotting concentration against peak area.
A Camag HPTLC system comprising of Linnomat V automatic sample applicator, Hamilton syringe, Camag TLC scanner-3, Camag Win CAT software, Camag twin trough chamber and as stationary phase, precoated silica gel 60F 254 were used. TLC plates were prewashed with methanol. Activation of plates was done in an oven at 50 0 for 5 min. The chromatographic conditions maintained were precoated silica gel 60F 254 aluminum sheets as stationary phase, ethyl acetate: toluene: methanol: ammonium hydroxide (1:6:2:0.1 v/v/v/v) as mobile phase, chamber and plate saturation time of 30 min, migration distance allowed was 80 mm, scanning was done at 282 nm keeping the slit dimension at 6 x 0.45 mm. A deuterium lamp provided the source of radiation.
Aliquots (1.0, 2.0, 3.0, 4.0, 5.0 and 6.0 µl) of standard solution (100 µg/ml) of NBH were applied on the precoated silica gel 60F 254 TLC plate. The TLC plate was dried, developed and analyzed photometrically as described earlier. Calibration curve was constructed by plotting peak area against concentration.
Assay of two different marketed tablets with brand names Nodon (5.0 mg, Brand I) and Nebicard (2.5 mg, Brand II) were performed. Twenty tablets of the above brands were separately weighed and powdered. The powder equivalent to 25 mg of NBH was dissolved in methanol to obtain 1 mg/ml, and was ultrasonicated and Þ ltered through 0.45 micron membrane Þ lter. The solution was further diluted with the mobile phase for HPLC and with methanol for HPTLC, and subjected for HPLC and HPTLC analysis as described earlier. From the peak area of NBH, the amount of drug in sample was computed.
To optimize the HPLC parameters, several mobile phase compositions were tried. Satisfactory peak symmetry was obtained with mobile phase consisting of 50 mM KH 2 PO 4 (pH was adjusted to 3.0 ± 0.1 with 10% v/v o-phosphoric acid):acetonitrile (45:55 v/v). QuantiÞ cation was achieved with UV detection at 282 nm based on peak area. The retention time was 3.76±0.02.
As per the USP XXIII 7 , system suitability tests for HPLC were carried out on freshly prepared standard stock solution of NBH and the parameters studied and results obtained with 20 µl injection volumes are summarized in Table 1 .
In HPTLC method several combinations of solvents were tried to accomplish separation. Using solvent system ethyl acetate: toluene: methanol: ammonium hydroxide (1:6:2:0.1 v/v/v/v) and precoated silica gel 60F 254 aluminum plate as stationary phase, good separation was attained, where R f was found to be at 0.33±0.02. The quantiÞ cation of the drug was carried at 282 nm wavelength.
The linear regression data showed a good linear relationship over a concentration range of 10 to 150 µg/ml for HPLC and 100 to 600 ng/spot for HPTLC. The limit of detection and the limit of quantiÞ cation for HPLC was found to be 2.0 and 10.0 μg/ml, respectively, and for HPTLC as 30 and 100 ng/spot, respectively. The intra-day and inter-day precision were determined by analyzing standard solutions in the concentration range of 20 to 100 µg/ml for HPLC and 150 to 550 ng/spot for HPTLC. The intra-day and inter-day results indicate that both methods are precise ( Table 2 ). Repeatability of HPLC method was assayed by injecting 40 µg/ml for five times and peak area was measured. The % RSD was found to be 0.002. In HPTLC, 350 ng/spot was applied Þ ve times on a TLC plate followed by development of plate and recording the peak area. The % RSD was found to be 1.860. The spot was scanned five times without changing the position of the plate and % RSD was found to be 1.649 (Table 1) .
Assay results of both the brands are very close to the label claim. To study accuracy of the developed methods, recovery studies were carried out using standard addition method at four different levels for both the brands and the % recoveries were calculated ( Table 3) . The results revealed no interference of excipients. The proposed RP-HPLC and HPTLC methods are accurate, precise, sensitive, selective and rapid. Both the methods can be used for routine analysis of nebivolol hydrochloride in the tablet dosage form.
